1. Volume 140, Issue 6, Pages 1817-1826.e2 (May 2011)
The Utility of Biomarkers in the Diagnosis and Therapy of Inflammatory Bowel Disease 
James D. Lewis 
Gastroenterology 
Volume 140, Issue 6, Pages e2 (May 2011)
DOI: /j.gastro
Copyright © 2011 AGA Institute Terms and Conditions

2. Figure 1
The potential role of biomarker assays in the care of patients with suspected or established IBD. Biomarkers might be used in all phases of the care. For patients with suspected IBD, biomarkers can be used to select which patients are unlikely to have IBD and could forgo further testing. Once patients are diagnosed, biomarkers can be used to determine which patients have CD or UC and to predict disease course. Biomarkers might be used to determine which patients are most likely to respond to therapies and determine prognosis and to identify those who require more aggressive therapies. In patients with recurrent symptoms, biomarkers can differentiate patients with active inflammation from those likely to have symptoms from other causes.
Gastroenterology  , e2DOI: ( /j.gastro )
Copyright © 2011 AGA Institute Terms and Conditions

3. Gastroenterology 2011 140, 1817-1826. e2DOI: (10. 1053/j. gastro. 2010
Copyright © 2011 AGA Institute Terms and Conditions